(October 2022)
This is a general overview of the Federal Motor Carrier Safety
Administration's (FMCSA) alcohol and drug testing rules for persons required to
obtain a commercial driver's license (CDL). It is only a general summary of the
rules and does not contain many of the requirements or special circumstances
detailed in the FMCSA and Department of Transportation (DOT) rules.
Note: Additional information is available at the FMCSA WEBSITE: www.fmcsa.dot.gov
FMCSA regulations require alcohol and drug testing of all drivers who are required to have a Commercial Drivers License (CDL) for the type of vehicle they operate. DOT rules include procedures for urine drug testing and breath-alcohol testing.
FMCSA rules apply to anyone who operates commercial motor vehicles requiring a CDL. Some examples are:
A driver is subject to the Act during any period in which he or she actually performs, is ready to perform, or is immediately available to perform a safety function. A safety function is defined as a function performed on duty time, further defined as follows:
Because alcohol is a legal substance, the rules define excluded alcohol-related conduct. Performing certain safety-sensitive functions is prohibited:
Refusal to submit to alcohol testing or use of alcohol within eight hours after an accident or until drivers required to be tested are tested is prohibited.
Required
Alcohol Tests
Four tests are required:
Random testing of a pool
of drivers takes place on an unannounced basis prior to, during, or immediately
after the driver performs certain functions. Testing dates and times are not announced ahead of time, and tests are
conducted at reasonable intervals during the year. The number of such tests the
employer does annually must equal or exceed 10% of the average number of
drivers subject to the regulations. Independent truckers must combine with
others to form their own testing pool.
Screening tests are performed using saliva devices or breath testing using approved National Highway Traffic Safety Administration (NHTSA) evidential breath testing (EBT) and non-evidential breath testing devices identified in the Federal Register.
Two tests are required to determine if a person has excessive alcohol concentration.
Testing procedures that address a number of different criteria are in place to ensure test result accuracy, reliability, and confidentiality.
The employer must implement and perform the tests. It uses its own employees or contract services to do so or joins a consortium that does so on behalf of its members. Law enforcement officers do not test in conjunction with roadside or other inspections but do post-accident tests under certain circumstances. Individuals doing the testing must understand the procedures and know how to operate the EBT.
Drivers involved in prohibited alcohol conduct must be removed from driving duties immediately and cannot resume those duties unless and until they are evaluated by trained professionals and comply with treatment programs that address their problem. In addition, drivers having an alcohol concentration that tested in excess of .02 prior to, during, and immediately after driving cannot resume driving duties for 24 hours. Drivers whose behavior or appearance suggests alcohol use must submit to a reasonable suspicion alcohol test or must be removed from driving duties for at least 24 hours.
Employers must inform their employees about the misuse of alcohol, their policy concerning it, testing requirements, and provide resources and information to address the issue. Driver supervisors must take part in a minimum of one hour of training on symptoms of alcohol misuse and be made aware of signs and indicators that might dictate further testing.
Drivers who violate rules concerning misuse of alcohol must be referred to appropriate professionals for evaluation and be provided with any treatment or rehabilitation according to the employer's policy or labor/management agreements. These rules do not require the employer to rehabilitate, pay for treatment, or reinstate drivers. Drivers returned to duty must have been evaluated by a substance abuse professional, complied with recommended treatment, taken a return-to-duty alcohol test with an acceptable result, and be subject to unannounced follow-up alcohol tests.
Employers must keep detailed records of their misuse of alcohol prevention programs and allow the FMCSA to inspect or audit them. In addition, certain employers are selected to prepare annual calendar year summary reports for the FMCSA to assist in monitoring compliance and enforcement of the rules and to provide data on the extent of misuse of alcohol and the need for future program and regulatory changes.
Test results and other confidential information are released to only the
employer and substance abuse professionals. Another
release of this information requires the driver's written consent. Employers
may release certain information to the appropriate parties in cases where a
driver initiates a grievance, hearing, lawsuit, or other action as a result of
violations of these rules.
FMCSA requires drivers for foreign motor carriers to comply with the alcohol rules when operating motor vehicles in the United States.
Five tests are required:
Note: These requirements apply to the same drivers as alcohol testing.
Drug testing involves analyzing drivers' urine specimens at laboratories identified in the Federal Register that the Department of Health and Human Services (DHHS) certifies and monitors. Drivers provide urine specimens in a private location. The collector seals and labels the specimens. A chain of custody document, the specimens, and accompanying paperwork are then shipped to the drug-testing laboratory. These collection procedures and the chain of custody ensure that the specimens are secure, properly identified, and not compromised.
Urine specimens are analyzed for marijuana, cocaine, amphetamines,
opiates (heroin) and phencyclidine (PCP).
Review
and Interpretation of Laboratory Results
A physician or Medical Review Officer (MRO) reviews and interprets all drug test results before reporting them to the employer. If a laboratory report is positive, the MRO contacts and interviews the driver to determine if there is any other medical explanation for the drugs found in the urine specimen. If there is an acceptable and legitimate medical explanation, the MRO informs the employer that the drug test is negative.
Drug rules prohibit any unauthorized use of controlled substances by
drivers on or off duty. FMCSA has additional rules prohibiting the use of legally prescribed controlled
substances, such as barbiturates, amphetamines, and morphine, by drivers
engaged in interstate commerce.
Note: The marijuana rule applies even in states
where marijuana use has been legalized. This is a federal rule which continues
to view marijuana as a controlled substance.
Drivers having positive drug test results must be removed from driving duties if the MRO investigation determines that the positive test result was due to unauthorized use of a controlled substance. Drivers cannot resume driving duties until evaluation by a substance abuse professional is complete, recommendations for rehabilitation complied with, and the return-to-duty test result is negative. Follow-up testing is required to verify that the driver continues to abstain from drug use.
Employers must conduct random drug tests on 50% or more of their drivers. This means that some drivers may be tested more than once each year and others not at all. Such testing does not necessarily have to be conducted in immediate time proximity to performing driving duties. However, a driver selected for testing must immediately go to a collection site upon notification.
Employers must inform drivers of available drug use and treatment information and resources. Employers and supervisors of drivers must take part in at least one hour of training on recognizing the signs and symptoms of drug abuse in order to assist them in making appropriate determinations for reasonable suspicion testing.
The employer, the drug-testing laboratory, and the MRO maintain
confidential driver drug testing results and records and do not release them
without the driver's written consent. These confidentiality provisions apply
with limited exceptions for decision makers in arbitration, litigation, or
administrative proceedings due to positive drug tests. Employers and
drug-testing laboratories maintain statistical records and reports in aggregate
form to monitor compliance with the rules and to assess the effectiveness of
the drug testing programs.